← Open Payments lookup

KASEY BUCHANAN: Open Payments

NPI 1972187607 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,507 in 127 payments from 17 companies in 2025. Trend: 2023 $1,641 · 2024 $1,706 · 2025 $2,507

Food & beverage: $2,497Education: $10
CompanyPaymentsAmount
ABBVIE INC.39$689
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$378
Madrigal Pharmaceuticals12$304
Takeda Pharmaceuticals U.S.A., Inc.14$279
Janssen Biotech, Inc.15$246
Gilead Sciences, Inc.6$158
PFIZER INC.5$93
QOL Medical, LLC3$86
Phathom Pharmaceuticals, Inc.5$79
Aimmune Therapeutics, Inc.2$46

Products named: XIFAXAN, REZDIFFRA, RINVOQ, ENTYVIO, TREMFYA, CREON, LINZESS, VELSIPITY.

Industry payments across GA — which companies pay providers there.